Tenet Healthcare Corporation (THC)
Tenet (THC) Upgraded to Buy: Here's Why
Tenet (THC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Tenet Healthcare (THC) Laps the Stock Market: Here's Why
Tenet Healthcare (THC) closed the most recent trading day at $179.11, moving +2.55% from the previous trading session.
Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
3 Reasons Why Growth Investors Shouldn't Overlook Tenet (THC)
Tenet (THC) possesses solid growth attributes, which could help it handily outperform the market.
Is It Worth Investing in Tenet (THC) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Tenet Healthcare (THC) Stock Dips While Market Gains: Key Facts
Tenet Healthcare (THC) closed the most recent trading day at $161.37, moving 2.11% from the previous trading session.
Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on It
Tenet (THC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Tenet Healthcare Corporation's Regulatory Woes Don't Put It In The ER
Tenet Healthcare Corporation remains a compelling Buy, supported by strong financial performance and deeply discounted valuation versus peers. Despite a recent 22.7% stock decline and regulatory headwinds, THC's Ambulatory Care segment shows resilience, with revenue up from $1.19B to $1.32B and profit growth. Management guides for 2026 revenue of $21.5B–$22.3B, EBITDA of $4.485B–$4.785B, and adjusted net profits of $1.425B–$1.625B.
Here's Why Tenet Healthcare (THC) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Tenet Healthcare (THC) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
